Medical Information
United States

In order to provide you with relevant and meaningful content we need to know more about you.

Please choose the category that best describes you.

This content is intended for U.S. Healthcare Professionals. Would you like to proceed?

If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents.

Our scientific content is evidence-based, scientifically balanced and non-promotional. It undergoes rigorous internal medical review and is updated regularly to reflect new information.

TALZENNA How Supplied/Storage and Handling (talazoparib)


TALZENNA is supplied in strengths and package configurations as described in Table 6:

Table 6. TALZENNA Capsules
Package ConfigurationCapsule Strength (mg)NDCPrint
Bottles of 30 capsules0.25NDC: 0069-0296-30Ivory cap (printed with "Pfizer" in black) and a white body (printed with "TLZ 0.25" in black).
Bottles of 30 capsules0.5NDC: 0069-1501-30Light pink cap (printed with "Pfizer" in black) and a white body (printed with "TLZ 0.5" in black).
Bottles of 30 capsules0.75NDC: 0069-1751-30Light orange cap (printed with "Pfizer" in black) and a white body (printed with "TLZ 0.75" in black).
Bottles of 30 capsules1NDC: 0069-1195-30Light red cap (printed with "Pfizer" in black) and a white body (printed with "TLZ 1" in black).


Store at 20°C to 25°C (68°F to 77°F); excursions permitted between 15°C to 30°C (59°F to 86°F). [See USP Controlled Room Temperature].

Did you find an answer to your question? Yes No
Didn’t find what you were looking for? Contact us.
Report Adverse Event